Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: A cohort study

Journal of Hematology & Oncology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2w64Akj
via IFTTT